High-performance liquid chromatographic assay for the quantitation of irbesartan (SR 47436/BMS-186295) in human plasma and urine

Journal of Chromatography B: Biomedical Applications

Volumn 702, Issue 1-2, 1997, Pages 149-155

  Chang, Shu Ying ^a   Whigan, Daisy B ^a   Vachharajani, Nimish N ^b   Patel, Rajesh ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b PRINCETON UNIVERSITY   (United States)

Author keywords

Angiotensin II antagonist; BMS 186295; Irbesartan; SR 47436

Indexed keywords

ACETONITRILE; ANGIOTENSIN II ANTAGONIST; BMS 190462; IRBESARTAN; PHOSPHATE; TRIETHYLAMINE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG URINE LEVEL; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SOLID PHASE EXTRACTION;

ADMINISTRATION, ORAL; ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCADIAN RHYTHM; DRUG STABILITY; HUMANS; LINEAR MODELS; MALE; OSMOLAR CONCENTRATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TETRAZOLES; TIME FACTORS;

EID: 0031582878     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(97)00387-3     Document Type: Article

References (12)

1. Ondetti M., Rubin B., Cushman D. Science. 196:1977;441.
2. Cazaubon C., Gougat J., Bousquet F., Guiraudou P., Gayraud R., Lacour C., Roccon A., Galindo G., Barthelemy G., Gautret B., Bernhart C., Perreaut P., Brelière J.C., Le Fur G., Nisato D. J. Pharmacol. Exp. Ther. 265:1993;826.
3. Eberhardt R.T., Kevak R.M., Kang P.M., Frishman W.H. J. Clin. Pharmacol. 33:1993;1023.
4. Gottlieb S.S., Dickstein K., Fleck E., Kostis J., Levine T.B., LeJemtel T., DeKock M. Circulation. 88:1993;1602.
5. Lacourcière Y., Brunner H., Irwin R., Karlberg B.E., Ramsay L.E., Snavely D.B., Dobbins T.W., Faison E.P., Nelson E.B. J. Hypertens. 12:1994;1387.
6. Ribstein J., Sissmann J., Picard A., Bouroudian M., Mimran A. J. Hypertens. 12:1994;131.
7. Sissmann J., Bouroudian M., Armagnac C., Donazollo Y., Latreille M., Panis R. J. Hypertens. 12:1994;S92.
8. Van den Meiracker A.H., Admiraal P.J., Janssen J.A., Kroodsma J.M., de Ronde W.A., Boomsma F., Sissmann J., Blankestijn P.J., Mulder P.G., Man In't Veld A.J., Schalekamp M.A.D.H. Hypertension. 25:1995;22.
9. Shah V.P., Midha K.K., Dighe S., McGilveray I.J., Skelly J.P., Yacobi A., Layloff T., Viswanathan C.T., Cook C.E., McDowall R.D. Eur. J. Drug Metab. Pharmacokinet. 16:1991;249.
10. T. Chando, D. Everett, A. Kahle, A. Starrett, N. Vachharajani, W. C. Shyu, K. J. Kripalani and R. H. Barbhaiya, Proceedings of the Seventh North American ISSX Meeting, San Diego, CA, 1996, p. 322.
11. M. Gibaldi and D. Perrier, Pharmacokinetics, 2nd edition, Marcel Dekker, New York, 1982, pp. 409-417.
12. Riegelman S., Collier P. J. Pharmacokinet. Biopharm. 8:1980;509.